Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants
Despite successful treatments, hepatitis C virus (HCV) infections continue to be a significant world health problem. High treatment costs, the high number of undiagnosed individuals, and the difficulty to access to treatment, particularly in marginalized susceptible populations, make it improbable t...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
MDPI AG
2020-06-01
|
| Rangatū: | Vaccines |
| Ngā marau: | |
| Urunga tuihono: | https://www.mdpi.com/2076-393X/8/2/313 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|